Home

BetaShares Global Healthcare ETF - Currency Hedged (DRUG)

About this Fund

Fund Detail

PDS https://informedinvestor.com.au/view/pds/106506-2023-01-06-02:20.pdf
FUND MANAGER BetaShares Capital
ASX Code DRUG*
APIR
ASSET CLASS EXCHANGE TRADED FUNDS
INVESTMENT STYLE

Aims to track the performance of the Benchmark, before fees and expenses.

INVESTMENT PROFILE

The Index is designed to track the performance of global companies that are in the Healthcare sector (excluding companies listed in Australia).

CURRENCY MANAGEMENT Hedged
INCEPTION DATE 04-08-2016
BENCHMARK Nasdaq Global ex-Australia Healthcare Hedged AUD Index
FUND SIZE Nasdaq Global ex-Australia Healthcare Hedged AUD Index
DISTRIBUTION FREQUENCY Half yearly
NO. OF HOLDINGS up to 60 securities.
FEES 0.47% p.a.
STRUCTURE

Benefits

Benefits

Healthcare Sector Exposure

DRUG provides instant exposure to the performance of the largest international healthcare companies, including Johnson & Johnson, Pfizer and Roche.

Growth Opportunity

Due to ageing populations, rising living standards and ongoing medical advancements, healthcare is anticipated to remain one of the global economy’s leading growth sectors for some time.

Large Company Exposure

DRUG invests only in the most significant healthcare companies globally

Reduced Currency Risk

DRUG is hedged to the Australian Dollar, substantially eliminating the effects of currency fluctuations on returns. 

ASX: DRUG is part of our global sector fund series

The Global Sector Series is designed to provide investors with a convenient and costeffective way to access the largest companies in some of the world’s most important industry sectors in a single ASX trade.

 

RISK LEVEL Very high
INVESTOR SUITABILITY

DRUG can be used by investors for a variety of investment strategies, for example:
• A core building block for a global shares allocation
• Tactical exposure to the global healthcare sector

Risks

Title
Detail

Key Features

The investment objective of the BetaShares Global Healthcare ETF - Currency Hedged is to provide an investment return that aims to track the performance of the Nasdaq Global exAustralia Healthcare Hedged AUD Index (the “Index”), before taking into account fees and expenses.

The Index is designed to track the performance of global companies that are in the Healthcare sector (excluding companies listed in Australia). 

Mandate

The Fund will seek to achieve the investment objective by adopting a “full replication” strategy. 

The index sponsor is the Nasdaq, Inc (“Nasdaq”). Nasdaq operates one of the world’s largest networks of exchanges, which spans 26 markets and six continents. Nasdaq is a public company listed on the NASDAQ Global Select Market. Within its index business, it calculates over 40,000 diverse indexes that provide coverage across asset classes, countries and sectors. To be eligible for initial inclusion in the Index, a security must meet the following criteria:
• must be a member of the NASDAQ Global Large Cap Index (NQGLCI);
• must have a country classification from an eligible country (see table of eligible countries below); and
• must be classified as “Healthcare” per the Industry Classification Benchmark (ICB).